The past few years have witnessed remarkable advancements in treatment of heart disease and such remarkable advancements will definitely change the world of medicine for the better as explained here below.

Drug for treating heart failure

Heart failure is one of the most common heart disorders which are usually characterized by the muscles of the heart not being able to pump blood into the tissues of the body. The most common causes of this ailment are heart attacks and high blood pressure as well as diseases, which make heart muscles weak. The patient usually experiences breath shortness and fatigue and this make their life less enjoyable. Paradigm- HF was a major clinical trial which used a drug known as LCZ696 for treatment of heart failure. The drug showed enhanced effectiveness and was able to reduce repeat hospitalization or death by as much as 20 percent. Presents, about 20% of heart failure patients get readmitted to the hospital within 30 days, but this drug has reduced the burden on the healthcare system in a remarkable way.

Treatment for high cholesterol

PSCK9 inhibitor is the next highly innovative drug therapy and the drug has been one of the major representations of the remarkable advancements made in the world of cardiovascular in recent times. High levels of LDL-C or ‘bad’ cholesterol is a major risk factor for coronary heart disease and statins are the best drugs available for cholesterol reduction. These drugs have reduced heart attack risk and stroke by as much as 35 percent. For over 25 years, statins have enjoyed enormous success in dealing with heart disease. Some patients unfortunately are not able to tolerate these drugs while others are not able to them in dosages large enough to reduce the levels of cholesterol adequately. But PSCK9 inhibitors have been remarkable in reduction of bad cholesterol to between 50 and 70 percent. An automated injector can be used by the patient to self inject easily and reap the remarkable benefits.

Less invasive surgical operation for treating heart valve disease

A new medical procedure for treatment of heart valve disease with no need of undertaking a major surgical operation was approved by FDA in 2011. TAVR involves the use of a device for treating patients who need to have their aortic valve replaced but pose excessively high risks to undergo the standard open heart surgery. For older patients and those who are too ill to get an open chest procedure, this is a great approach worth considering. Initially, TAVR was performed only at many academic medical centers at the start, but recent times have seen it become one of the major treatments being practiced all over the globe. And the good thing is that the treatment has proven to be very effective in containing heart valve disease.